Oura acquires AI healthcare platform counsel health for $625 million to bolster medical offerings

Oura has finalized the purchase of Counsel Health, an AI-driven primary care provider, for $625 million. This acquisition follows Oura's indefinite postponement of its planned IPO, which was attributed to market uncertainty. Counsel Health, which integrates chat-based medical advice with licensed physician access, was previously integrated into the Oura application in June. The combined entities aim to broaden their scope across preventative, acute, and specialty/chronic care. Counsel CEO Muthu Alagappan will join Oura as chief clinical AI officer. Alagappan noted that Oura's biometric data provides clinicians with objective context for delivering more informed care, emphasizing that Counsel built its AI around trust and safety. Financially, Oura recently reported 153% year-over-year revenue growth to $533 million for the quarter ending September 30, and generated $1.75 billion in revenue for fiscal year 2026. The company reached an $11 billion valuation after a $900 million late-stage funding round in October 2025. The deal is anticipated to conclude before the end of 2027.